New probe aims to stop post-polypectomy bleeding in high-risk patients
NCT ID NCT02875353
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests a special probe that checks blood flow in ulcers left after colon polyp removal. The goal is to see if using this probe to guide treatment can prevent delayed bleeding, especially in patients taking blood thinners or with large polyps. About 180 high-risk adults will be randomly assigned to either standard care or probe-guided care, and bleeding rates will be compared over 30 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELAYED POST-POLYPECTOMY INDUCED ULCER HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaiser Permanente-Downey Medical Center
Downey, California, 90242, United States
-
University of California, Los Angeles, Ronald Reagan Medical Center
Los Angeles, California, 90095, United States
-
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, 90073-1003, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Doppler endoscopic probe (a device that detects blood flow)
What this could lead to
If successful, this device could become a standard tool to prevent dangerous delayed bleeding after colon polyp removal, especially for patients on blood thinners.
What could go wrong
This is a relatively small, early-stage trial (180 participants) and the device may not reduce bleeding rates significantly compared to standard care. The procedure also carries its own minor risks.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.